Scotiabank Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $133
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $122
Truist Financial Maintains Arcellx(ACLX.US) With Buy Rating, Cuts Target Price to $134
Arcellx Is Maintained at Buy by Truist Securities
Arcellx Analyst Ratings
Truist Financial Maintains Arcellx(ACLX.US) With Buy Rating, Announces Target Price $136
Scotiabank Maintains Arcellx(ACLX.US) With Buy Rating, Raises Target Price to $133
Scotiabank Remains a Buy on Arcellx Inc (ACLX)
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $122
Piper Sandler Maintains Overweight on Arcellx, Raises Price Target to $115
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $111 to $115
Arcellx Is Maintained at Buy by Needham
Arcellx Analyst Ratings
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $91 to $120
Morgan Stanley Adjusts Arcellx's Price Target to $106 From $81, Keeps Overweight Rating
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $91 to $106
Arcellx Inc (ACLX) Gets a Buy From Scotiabank
Arcellx Is Maintained at Outperform by Baird
Arcellx Analyst Ratings
Promising Efficacy and Safety Profile of Arcellx Inc's IMMagine-1 Trial Leads to Buy Rating